BSX or DIVISLAB.NS: which has stronger momentum now?
As of 2026-09-01: BSX LONG (18 bars, uPnL -3.6%, total return -24.4%) vs DIVISLAB.NS LONG (218 bars, uPnL +40.9%, total return +25.3%). Momentum is the fourth gate — quality and valuation ceilings come first.
| Snapshot | 2026-09-01 · source: yahoo | |
|---|---|---|
| BSX (Boston Scientific) | DIVISLAB.NS (Divi's Laboratories) | |
| Market / sector | us · Healthcare | in · Pharma |
| Price | $46.67 | ₹9,121 |
| Quality score | 100/100 | —/100 |
| Engine signal | LONG · 18 bars · uPnL -3.6% | LONG · 218 bars · uPnL +40.9% |
| Total return | -24.4% | +25.3% |
Cite this page
Balance Labs Research Desk (2026-09-01). "BSX or DIVISLAB.NS: which has stronger momentum now?." balancelabs.app · https://balancelabs.app/stocks/compare/bsx-vs-divislab.ns/q/bsx-or-divislab.ns-stronger-momentum · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← BSX vs DIVISLAB.NS · snapshot 2026-09-01 · not investment advice